| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
caspase 3 | 0.351 | 0.923 | 0.10 |
|
disease | 0.600 | None | 0.980 | 50 | 2 | 1999 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
disease | 0.100 | None | 0.957 | 47 | 0 | 2004 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
disease | 0.100 | None | 0.957 | 47 | 0 | 2004 | 2019 | ||||||||
|
peptidylprolyl cis/trans isomerase, NIMA-interacting 1 | 0.488 | 0.769 | 0.74 |
|
disease | 0.300 | None | 0.979 | 47 | 2 | 2001 | 2019 | ||||||||
|
cystatin C | 0.436 | 0.808 | 3.9E-03 |
|
disease | 0.400 | None | 0.935 | 46 | 1 | 1988 | 2019 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 0.978 | 46 | 1 | 1999 | 2019 | ||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
disease | 0.300 | None | 0.935 | 46 | 2 | 1996 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.957 | 46 | 0 | 2004 | 2019 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
disease | 0.100 | None | 0.957 | 46 | 0 | 2004 | 2019 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
disease | 0.100 | None | 0.935 | 46 | 2 | 1996 | 2019 | ||||||||
|
protein phosphatase 2 phosphatase activator | 0.480 | 0.846 | 0.99 |
|
disease | 0.100 | None | 1.000 | 44 | 1 | 2003 | 2020 | ||||||||
|
cytochrome P450 family 46 subfamily A member 1 | 0.659 | 0.500 | 0.99 |
|
disease | 0.400 | None | 0.953 | 43 | 5 | 2000 | 2019 | ||||||||
|
NLR family pyrin domain containing 3 | 0.361 | 0.962 | 8.1E-04 |
|
disease | 0.100 | None | 1.000 | 43 | 0 | 2013 | 2019 | ||||||||
|
low density lipoprotein receptor | 0.449 | 0.885 | 9.8E-24 |
|
disease | 0.100 | None | 0.929 | 42 | 7 | 1997 | 2019 | ||||||||
|
insulin like growth factor 1 | 0.318 | 0.885 | 0.27 |
|
disease | 0.400 | None | 1.000 | 41 | 2 | 2000 | 2020 | ||||||||
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.100 | None | 0.976 | 41 | 2 | 2001 | 2020 | ||||||||
|
mitogen-activated protein kinase 1 | 0.330 | 0.923 | 1.00 |
|
disease | 0.100 | None | 1.000 | 41 | 1 | 2000 | 2020 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.100 | None | 0.927 | 41 | 6 | 1999 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.100 | None | 1.000 | 40 | 0 | 2005 | 2019 | ||||||||
|
alpha-2-macroglobulin | 0.529 | 0.769 | 4.5E-11 |
|
disease | 0.500 | None | 0.769 | 39 | 2 | 1998 | 2018 | ||||||||
|
dual specificity tyrosine phosphorylation regulated kinase 1A | 0.533 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 2005 | 2020 | ||||||||
|
monoamine oxidase B | 0.533 | 0.808 | 1.00 |
|
disease | 0.400 | None | 1.000 | 38 | 1 | 1994 | 2020 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
disease | 0.400 | None | 0.868 | 38 | 4 | 1999 | 2018 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.100 | None | 1.000 | 38 | 0 | 1997 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
disease | 0.100 | None | 0.895 | 38 | 0 | 1993 | 2019 |